![Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F121164%2Fteva-logo.png&w=1200&h=630&op=resize)
Teva Pharmaceutical Industries Ltd. Meets Earnings Targets Despite a Mild European Winter | The Motley Fool
![Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $ Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $](https://pbs.twimg.com/media/FYqw3KXXoAADt8_.jpg)
Teva Pharmaceuticals on Twitter: "Our live Q2 2022 earnings call is starting soon! Join President & CEO Kåre Schultz to discuss Teva's business performance and plans ahead. Join here: https://t.co/VR9FyBqEz2 #QuarterlyResults #Earnings $
![Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/381/31381/slides/1.jpg?1533221712)
Teva Pharmaceutical Industries Limited 2018 Q2 - Results - Earnings Call Slides (NYSE:TEVA) | Seeking Alpha
![Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD](https://www.investors.com/wp-content/uploads/2017/02/IT07-teva-022817-company.jpg)